Cargando…
Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells
PURPOSE: A previous study has identified that XRCC4-like factor (XLF) is a potential target to overcome resistance to 5-fluorouracil (5-Fu) and oxaliplatin (OXA) in colorectal cancer (CRC). The purpose of this study is to develop potent XLF inhibitors to chemoresistance in CRC. METHODS: Virtual scre...
Autores principales: | Liu, Zhuo, Yu, Miao, Fei, Bingyuan, Sun, Jing, Wang, Dongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847993/ https://www.ncbi.nlm.nih.gov/pubmed/31806933 http://dx.doi.org/10.2147/DDDT.S215967 |
Ejemplares similares
-
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
por: Liu, Zhuo, et al.
Publicado: (2019) -
Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023) -
Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
por: Cao, Yaoquan, et al.
Publicado: (2023) -
Overcoming Chemoresistance via Extracellular Vesicle Inhibition
por: Hayatudin, Raeesah, et al.
Publicado: (2021) -
Inhibition of PC4 radiosensitizes non‐small cell lung cancer by transcriptionally suppressing XLF
por: Zhang, Tian, et al.
Publicado: (2018)